Author:
Danpanichkul Pojsakorn,Suparan Kanokphong,Sukphutanan Banthoon,Kaeosri Chuthathip,Tothanarungroj Primrose,Sirimangklanurak Supapitch,Kalligeros Markos,Polpichai Natchaya,Pang Yanfang,Wijarnpreecha Karn,Sripongpun Pimsiri,Chamroonkul Naichaya,Nguyen Mindie H.,Liangpunsakul Suthat,Piratvisuth Teerha,Kaewdech Apichat
Funder
Faculty of Medicine, Prince of Songkla University
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 7(1), 6 (2021).
2. Buettner, S., van Vugt, J. L., IJzermans, J. N. & Groot Koerkamp, B. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 10, 1131–42 (2017).
3. Altekruse, S. F., Devesa, S. S., Dickie, L. A., McGlynn, K. A. & Kleiner, D. E. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J. Regist. Manag. 38(4), 201–205 (2011).
4. Rumgay, H. et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J. Hepatol. 77(6), 1598–1606 (2022).
5. McGlynn, K. A., Petrick, J. L. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma. Hepatology. 73(Supp 1), 4–13 (2021).